INO - Inovio Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue30,481.89742,220.08635,368.36140,572.111
Cost of Revenue95,257.87698,572.61888,712.03557,791.923
Gross Profit-64,775.979-56,352.532-53,343.674-17,219.812
Operating Expenses
Research Development----
Selling General and Administrative29,315.15928,290.36923,892.26318,063.89
Non Recurring----
Others----
Total Operating Expenses124,573.035126,862.987112,604.29875,855.813
Operating Income or Loss-94,091.138-84,642.901-77,235.937-35,283.702
Income from Continuing Operations
Total Other Income/Expenses Net-706.881-3,562.8713,495.5984,083.099
Earnings Before Interest and Taxes-94,091.138-84,642.901-77,235.937-35,283.702
Interest Expense----
Income Before Tax-94,798.019-88,205.772-73,740.339-31,200.603
Income Tax Expense2,169.811---2,097.766
Minority Interest96.26996.26996.269245.828
Net Income From Continuing Ops-96,967.83-88,205.772-73,740.339-29,102.837
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-96,967.83-88,205.772-73,740.339-29,187.606
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-96,967.83-88,205.772-73,740.339-29,187.606